Aerovate stockholders elect Dorval and Resnick as Class II directors; ratify KPMG as auditor

Jade Biosciences, Inc.

Allison Dorval elected with 18,685,353 votes for and 366,333 withheld; Joshua Resnick elected with 18,169,764 for and 881,922 withheld.
Ratification of KPMG LLP as independent auditor for FY2023 passed with 21,184,481 votes for, 0 against, 201 abstain.
Meeting held June 6, 2023; no other matters voted on.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Jade Biosciences, Inc. shareholders approved Elect each of Allison Dorval and Joshua Resnick, M.D. as Class II directors at the 2023-06-06 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-06

Exact text from the filing

The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee Votes For Votes Withheld Broker Non-Votes Allison Dorval 18,685,353 366,333 2,132,996 Joshua Resnick, M.D. 18,169,764 881,922 2,132,996

View on SEC.gov

58 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Jade Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001798749-23-000042

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.